Children with severe enterovirus A71 infection

Wenjuan Wu1, Baoguang Li2, Tao Xie3

  • 1Department of Neurology, Hebei Children's Hospital, Hebei Children's Hospital of Hebei Medical University, Hebei Provincial Key Laboratory of Pediatric Epilepsy and Neurological Diseases, 133 Jianhua Nan street, Shijiazhuang, 050031, China.

BMC Pediatrics
|April 13, 2023
PubMed

Insights

Enterovirus A71 (EV-A71) infection in children often presents with fever, rash, irritability, and lethargy. Neurological imaging may show abnormalities, and cerebrospinal fluid analysis can reveal increased white blood cells and neutrophils.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Neurology

Background:

  • Enterovirus A71 (EV-A71) infection is a significant concern in pediatric populations.
  • The timing of onset and specific symptoms of EV-A71 can be challenging to diagnose.
  • Severe EV-A71 infections require a better understanding of their clinical manifestations.

Purpose of the Study:

  • To investigate the clinical characteristics of severe enterovirus A71 (EV-A71) infection in children.
  • To identify common symptoms and neurological findings associated with severe EV-A71.
  • To explore potential correlations in cerebrospinal fluid parameters.

Main Methods:

  • A retrospective observational study was conducted.
  • Data from 101 children with severe EV-A71 infection admitted to Hebei Children's Hospital (January 2016-January 2018) were analyzed.
  • Clinical symptoms, neurological magnetic resonance imaging (MRI) findings, and cerebrospinal fluid (CSF) parameters were reviewed.

Main Results:

  • The study included 101 children (57 males, 44 females) aged 1-13 years.
  • Common symptoms included fever (93.1%), irritability (69.3%), lethargy (55.4%), and rash (45.5%).
  • Abnormal neurological MRI findings were observed in 19 patients, affecting areas like the pontine tegmentum, medulla oblongata, and cerebellum. A positive correlation was found between the neutrophil-to-white blood cell ratio in CSF within the first 3 days of illness (r=0.415, P<0.001).

Conclusions:

  • Severe EV-A71 infection in children typically presents with fever, rash, irritability, and lethargy.
  • Neurological involvement is common, as indicated by MRI findings.
  • Cerebrospinal fluid analysis, particularly the neutrophil and white blood cell counts, may aid in diagnosis.
Abstract

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
296
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
239
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
174
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
258
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
107